State Board of Administration of Florida Retirement System’s Quince Therapeutics QNCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-61
Closed -$76K 2390
2022
Q1
$76K Hold
61
﹤0.01% 2295
2021
Q4
$154K Hold
61
﹤0.01% 2266
2021
Q3
$1.12M Buy
61
+1
+2% +$15.9K ﹤0.01% 1358
2021
Q2
$638K Buy
60
+26
+76% +$218K ﹤0.01% 1722
2021
Q1
$243K Buy
+34
New +$245K ﹤0.01% 2136
2020
Q4
Sell
-34
Closed -$337K 2365
2020
Q3
$337K Buy
34
+7
+26% +$63.7K ﹤0.01% 1832
2020
Q2
$254K Buy
+27
New +$247K ﹤0.01% 1957

Other funds holding QNCX

State Board of Administration of Florida Retirement System's QNCX Position: Q2 2022 in Review

State Board of Administration of Florida Retirement System sold out of Quince Therapeutics (QNCX) in Q2 2022, closing a stake of 61 shares — an estimated $76K sold.

State Board of Administration of Florida Retirement System first reported a position in QNCX in Q2 2020 and held it in 7 quarters. The position peaked at $1.12M in Q3 2021. 66 funds tracked by Wall St. Rank hold QNCX as of Q2 2022.

  • State Board of Administration of Florida Retirement System reported no remaining Quince Therapeutics position as of Q2 2022 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 61 Quince Therapeutics shares in Q2 2022, an estimated $76K.
  • State Board of Administration of Florida Retirement System first reported a position in Quince Therapeutics in Q2 2020 and held it in 7 quarters.
  • State Board of Administration of Florida Retirement System's Quince Therapeutics position peaked at $1.12M in Q3 2021.
  • 66 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2022.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2022, filed 5 Aug 2022.